211 filings
Page 4 of 11
424B5
hwej1f6s20x1jjoifs
28 Feb 22
Prospectus supplement for primary offering
5:12pm
S-8
zo5whxcxp
28 Feb 22
Registration of securities for employees
4:32pm
8-K
6k16sdxbfpkbl74gzzwl
28 Feb 22
Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
6:16am
8-K
1n8 14y4x
3 Feb 22
Entry into a Material Definitive Agreement
7:15am
8-K
4mqha9bolog
23 Nov 21
Entry into a Material Definitive Agreement
7:16am
EFFECT
z51a7a 64
19 Nov 21
Notice of effectiveness
12:15am
CORRESP
vv23r41
16 Nov 21
Correspondence with SEC
12:00am
UPLOAD
7pv25896gpx5k sedw
15 Nov 21
Letter from SEC
12:00am
8-K
3nz49n dm1b
9 Nov 21
Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
6:15am
8-K
b3ah0y200ul3gm2
29 Oct 21
Entry into a Material Definitive Agreement
5:25pm
8-K
6a9wb39rt1slc7ti
10 Sep 21
Other Events
7:50am
8-K
b6dclu93kw6q1
16 Aug 21
Mersana Therapeutics Announces Appointment of Tushar Misra, Ph.D., as Chief Manufacturing Officer
8:16am
8-K
tux0taoi9d6h3wz id6h
6 Aug 21
Mersana Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
6:30am
8-K
jg20wk5rlrk 29uf13q
17 Jun 21
Submission of Matters to a Vote of Security Holders
6:30am
S-8
qv1e6njpw2s1 5nl
10 May 21
Registration of securities for employees
5:20pm
8-K
57v72iwdw
10 May 21
Mersana Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update
5:00pm